SECsense Logo

Citius Pharmaceuticals, Inc. 8-K Report: Key Financial Updates Unveiled

$CTXR
Form 8-K
Filed on: 2024-12-20
Source
Citius Pharmaceuticals, Inc. 8-K Report: Key Financial Updates Unveiled

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Citius Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001506251
  • Ticker Symbol: CTXR
  • Exchange: NASDAQ
  • Company's Address: 11 Commerce Drive, 1st Floor, Cranford, NJ 07016
  • Contact Number: (908) 967-6677
  1. Filing Information:
  • Filing Type: 8-K (which indicates a report of unscheduled material events or corporate changes)
  • Filing Date: December 18, 2024
  1. Financial Metrics:
  • Common Stock Par Value: $0.001
  • Units of Measurement:
    • Currency: USD (United States Dollar)
    • Shares: Measured in shares
  1. Context Information:
  • Period Covered: The report pertains to the date of December 18, 2024.
  1. Significant Aspects:
  • The document is structured in XBRL format, which is commonly used for electronic filings with the SEC, facilitating data extraction and analysis.
  • The report likely includes important updates regarding the company's financial position or operational status, as indicated by the nature of the 8-K filing.

This summary encapsulates the essential aspects of the financial report, focusing on the company specifics, filing details, and key financial metrics. Further analysis could involve reviewing the actual content of the 8-K filing for detailed events or updates that prompted the report.